Skip to Content

KADIAN 100 mg (Morphine Sulfate Extended Release 100 mg)

Pill with imprint KADIAN 100 mg is Green, Capsule-shape and has been identified as Morphine Sulfate Extended Release 100 mg. It is supplied by Actavis.

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 100 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for KADIAN 100 mg

Morphine sulfate extended release 100 mg KADIAN 100 mg
Morphine sulfate extended release 100 mg KADIAN 100 mg
Morphine sulfate extended release 100 mg KADIAN 100 mg
Morphine sulfate extended release 100 mg KADIAN 100 mg

Morphine Sulfate Extended Release

Imprint
KADIAN 100 mg
Strength
100 mg
Color
Green
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Actavis

Labelers / Repackagers

NDC CodeLabeler / Repackager
00228-3507 Actavis Pharma, Inc.
49884-0838 Par Pharmaceutical, Inc.
52544-0164 Watson Pharmaceuticals, Inc.
54868-4573 Physicians Total Care Inc. (repackager)
35356-0052 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Related Images for "KADIAN 100 mg"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.